HSPH1 (Heat Shock Protein Family H1), also known as HSPA4 or HSP105. is a member of the heat shock protein 110 (HSP110) family, a subgroup of molecular chaperones within the broader HSP70 superfamily. It plays a critical role in protein homeostasis by assisting in protein folding, preventing aggregation under stress conditions, and facilitating the degradation of misfolded proteins via the ubiquitin-proteasome system. HSPH1 is highly conserved and expressed ubiquitously, with upregulated expression during cellular stress, such as heat shock, oxidative stress, or chemotherapeutic exposure.
Antibodies targeting HSPH1 are essential tools for studying its function, localization, and interactions in various biological contexts. They are widely used in techniques like Western blotting, immunofluorescence, immunoprecipitation, and immunohistochemistry to detect HSPH1 expression levels in tissues or cell lines. Research has linked HSPH1 overexpression to cancer progression, including roles in promoting tumor cell survival, metastasis, and chemoresistance, particularly in colorectal, breast, and pancreatic cancers. Its association with poor prognosis in certain malignancies has sparked interest in HSPH1 as a potential therapeutic target or biomarker.
Additionally, HSPH1 antibodies contribute to exploring its neuroprotective roles in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, where protein misfolding is a hallmark. These studies highlight HSPH1’s dual context-dependent roles in stress adaptation and disease pathogenesis.